NCT06534086

Brief Summary

It is standard practice for most cystoscopies and vasectomies in an office or outpatient setting to be performed under local anesthesia while the patient is awake and conscious. However, given the conscious nature of these procedures, patients may experience anxiety-inducing stressors that they otherwise would not under general anesthesia. Stressors such as hearing surgical terminology, technical discussion, and injection of local anesthetic have been previously documented as sources of perioperative anxiety and pain in awake surgeries. The current study will examine the feasibility and pilot outcomes of Virtual Reality (VR) guided meditation therapy during cystoscopies and vasectomies. Feasibility will be examined through: (1) recruitment capability and resulting sample characteristics, (2) data collection procedures (including randomization) and outcome measures, and (3) participant acceptability and suitability of the VR intervention during the procedures. The investigators will also evaluate pilot outcomes of the VR intervention on pain, anxiety, and overall satisfaction with the procedure. Results of this study will inform the development of a large-scale randomized clinical trial (RCT) to evaluate the efficacy of this intervention. Participants will be asked to complete questionnaires before and after their procedure and will be asked for a verbal measure of their pain and anxiety during the procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 6, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 12, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 2, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

January 23, 2025

Status Verified

August 1, 2024

Enrollment Period

5 months

First QC Date

July 12, 2024

Last Update Submit

January 20, 2025

Conditions

Keywords

feasibilityvirtual realityperioperative mental health

Outcome Measures

Primary Outcomes (5)

  • Recruitment rate

    Proportion of individuals who consent to participation and the number of recruited participants per week

    through study completion, up to 1 year

  • Inclusion criteria and demographic and surgery-related differences

    Proportion of individuals who meet inclusion criteria and any demographic and surgery-related differences in potentially eligible participants

    through study completion, up to 1 year

  • Retention of participants in the study

    Proportion of individuals who tolerate the intervention and complete the study

    Immediate post-operative

  • Acceptability through elevate scores on the Virtual Reality Impression Scale

    Acceptability of the VR program during urological procedures (0 thru 100, 100=positive impressions)

    Immediate post-operative

  • Impressions of the VR based on open-ended responses on the Virtual Reality Impression Scale

    Negative and positive impressions of the VR intervention (open ended/qualitative)

    Immediate post-operative

Secondary Outcomes (9)

  • Scores on the National Comprehensive Cancer Network (NCCN) Distress Thermometer (and adapted Anxiety Thermometer)

    Pre-operative, acute post-operative (immediately following surgery)

  • Visual Analogue Scale pain severity

    Peri-operative (mid-way through procedure)

  • Visual Analogue Scale anxiety severity

    Peri-operative (mid-way through procedure)

  • State Trait Anxiety Inventory (STAI) elevated scores

    Pre-operative, acute post-operative (immediately following surgery)

  • PROMIS Pain Intensity Scale total score

    Acute post-operative (immediately following surgery)

  • +4 more secondary outcomes

Study Arms (4)

Cystoscopy VR intervention

EXPERIMENTAL

Local anesthetic and VR intervention

Device: Virtual reality (VR) guided meditation therapy

Cystoscopy treatment as usual

ACTIVE COMPARATOR

Local anesthetic only

Other: Treatment as usual

Vasectomy VR intervention

EXPERIMENTAL

Local anesthetic and VR intervention

Device: Virtual reality (VR) guided meditation therapy

Vasectomy treatment as usual

ACTIVE COMPARATOR

Local anesthetic only

Other: Treatment as usual

Interventions

Tripp application on Meta Quest 3 VR headset

Cystoscopy VR interventionVasectomy VR intervention

No VR, local anesthetic only

Cystoscopy treatment as usualVasectomy treatment as usual

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • can speak and read English
  • have an indication for a cystoscopy or elected for a vasectomy
  • are scheduled to undergo their respective procedure under local anesthesia at the Men's Health Clinic between the dates of May-November 2024.

You may not qualify if:

  • those who are not competent to provide informed consent (e.g., due to cognitive impairment)
  • those who are unable to participate in a VR intervention (e.g., due to visual or auditory impairment)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Men's Health Clinic

Winnipeg, Manitoba, R3P 2S8, Canada

Location

MeSH Terms

Conditions

Anxiety DisordersPainPatient Satisfaction

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Mental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • RenĂ©e El-Gabalawy, PhD

    University of Manitoba

    PRINCIPAL INVESTIGATOR
  • Premal Patel, MD

    University of Manitoba

    PRINCIPAL INVESTIGATOR
  • Simone Gentile, BSc

    University of Manitoba

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Other = feasibility (primary) + clinical pilot outcomes (secondary)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 12, 2024

First Posted

August 2, 2024

Study Start

June 6, 2024

Primary Completion

November 1, 2024

Study Completion

November 1, 2024

Last Updated

January 23, 2025

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations